GlassScriptPhysician profile
Megan Fleming
NPI 1134997703
$7,058.89
in general payments reported to CMS, 2019-2025
22 companies · $5,550 in 2025
The $5,550 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,509 · 2025: $5,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,064 · Consulting Fee: $2,100 · Travel and Lodging: $676 · Education: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,063.56 |
| Consulting Fee | $2,100.00 |
| Travel and Lodging | $675.82 |
| Education | $219.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $3,198.35 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $951.39 | 2024-2025 | Tezspire, Fasenra, Airsupra |
| Regeneron Healthcare Solutions, INC. | $692.36 | 2024-2025 | Dupixent |
| Glaxosmithkline, LLC. | $576.13 | 2024-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Amgen INC. | $283.48 | 2024-2025 | Tezspire, Tavneos |
| Verona Pharma, INC. | $236.59 | 2025 | Ohtuvayre |
| Actelion Pharmaceuticals US, INC. | $188.26 | 2024-2025 | Opsumit, Uptravi |
| Philips North America LLC | $141.88 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.21 | 2024-2025 | Ofev, Jascayd |
| Insmed, INC. | $94.46 | 2025 | Brinsupri, Arikayce |
| Electromed, INC. | $91.02 | 2025 | Smartvest |
| United Therapeutics Corporation | $79.75 | 2024-2025 | Tyvaso, Tyvaso |
| Grifols USA, LLC | $77.83 | 2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $70.20 | 2024-2025 | Glassia, Cuvitru |
| Pfizer INC. | $60.76 | 2024-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $44.78 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $41.52 | 2025 | Inspire |
| Mallinckrodt Hospital Products INC. | $41.20 | 2025 | Acthar |
| Mylan Specialty L.P. | $36.49 | 2024 | Yupelri |
| Baxter Healthcare | $19.67 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Ani Pharmaceuticals, INC. | $18.63 | 2024 | Purified Cortrophin Gel |
| La Jolla Pharmaceutical Company | $14.93 | 2024 | Giapreza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Fleming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.